JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Tolcapone (Ro 40-7592; SOM-0226; Ro-407592; Tasmar), an approved anti-Parkinson's disease (PD) agent, is a reversible and orally bioavailable inhibitor of catechol-O-methyl transferase (COMT) with potential anti-PD effects. It inhibits COMT with Ki of 30 NM. COMTcatalyses a relatively minor pathway of dopamine metabolism, therefore the action of dopamine can be enhanced by tolcapone. Tolcapone is used in combination with levodopa for the treatment of Parkinson's disease (PD).
References: Adv Neurol. 1990; 53:497-503; Br J Pharmacol. 1996 Feb; 117(3):516-520.
Chemical Name: (3, 4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone
InChi Key: MIQPIUSUKVNLNT-UHFFFAOYSA-N
InChi Code: InChI=1S/C14H11NO5/c1-8-2-4-9(5-3-8)13(17)10-6-11(15(19)20)14(18)12(16)7-10/h2-7, 16, 18H, 1H3
SMILES Code: O=C(C1=CC([N+]([O-])=O)=C(O)C(O)=C1)C2=CC=C(C)C=C2
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!